Molecure S.A.

WSE:MOC Rapporto sulle azioni

Cap. di mercato: zł255.9m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Molecure Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Marcin Szumowski

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEO0.7%
Durata media del management3.6yrs
Durata media del Consiglio di amministrazione2.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

Is Molecure (WSE:MOC) In A Good Position To Deliver On Growth Plans?

Aug 20
Is Molecure (WSE:MOC) In A Good Position To Deliver On Growth Plans?

Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Apr 20
Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

We're Keeping An Eye On Molecure's (WSE:MOC) Cash Burn Rate

Dec 01
We're Keeping An Eye On Molecure's (WSE:MOC) Cash Burn Rate

Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Jul 07
Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Mar 10
Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Aug 16
Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

OncoArendi Therapeutics' (WSE:OAT) Earnings Are Weaker Than They Seem

Nov 04
OncoArendi Therapeutics' (WSE:OAT) Earnings Are Weaker Than They Seem

Is OncoArendi Therapeutics S.A.'s (WSE:OAT) Shareholder Ownership Skewed Towards Insiders?

Feb 24
Is OncoArendi Therapeutics S.A.'s (WSE:OAT) Shareholder Ownership Skewed Towards Insiders?

Will OncoArendi Therapeutics (WSE:OAT) Spend Its Cash Wisely?

Jan 02
Will OncoArendi Therapeutics (WSE:OAT) Spend Its Cash Wisely?

AMMINISTRATORE DELEGATO

Marcin Szumowski

no data

Mandato

zł548,043

Compensazione

Mr. Marcin Jan Szumowski, Ph D., is employed at Life Science Innovations Fund. He has been Chief Executive Officer and President of the Management Board at Molecure S.A. (formerly known as OncoArendi Thera...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Marcin Szumowski
Co-Founderno datazł548.04k0.70%
PLN 1.8m
Adam Golebiowski
Co-Founder & VP of Research Chemistry12.6yrszł500.00k3.01%
PLN 7.7m
Slawomir Broniarek
CFO & Member of the Management Boardno datazł414.20k0.20%
PLN 524.5k
Zbigniew Zaslona
Chief Scientific Officer & Member of Management Board2.6yrszł376.64k0.11%
PLN 287.1k
Agnieszka Rajczuk-Szczepanska
Member of Management Board & HR Director4.6yrszł345.44k0.034%
PLN 88.2k
Jacek Olczak
Co-Founder & Head of Medicinal Chemistryno dataNessun datoNessun dato
Samson Fung
Chief Medical Officer & Member of Management Board1.6yrsNessun datoNessun dato
Magdalena Tyszkiewicz
Head of CMC4.6yrsNessun datoNessun dato
Marta Borkowska
Director of the Management Board Office2.6yrsNessun datoNessun dato

3.6yrs

Durata media

Gestione esperta: Il team dirigenziale di MOC è considerato esperto (durata media dell'incarico 3.6 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Reynold A. Panettieri
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Bart Lambrecht
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Jakub Golab
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Tomasz Piec
Vice Chairman of the Supervisory Board4.6yrszł140.98kNessun dato
Douglas Hay
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Rafal Kaminski
Member of the Supervisory Board2.6yrszł63.46kNessun dato
Paul Van Der Horst
Member of Supervisory Board2.6yrszł117.62k0.059%
PLN 152.0k
Mariusz Gromek
Member of Supervisory Boardno datazł112.78kNessun dato
Piotr Zólkiewicz
Independent Chairman of Supervisory Board3.6yrszł197.37kNessun dato
Rafal Krenke
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Bruce Conway
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Nancy Van Osselaer
Member of the Supervisory Board & Member of Scientific Advisory Board2.8yrszł117.62kNessun dato

2.8yrs

Durata media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di MOC non è considerato esperto (durata media del mandato 2.8 anni), il che suggerisce un nuovo consiglio.